JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures
... to our customers."
Testing of the WaveReady
transport System was conducted at the Brocade
Data Center ... The WaveReady product line offers a flexible WDM
transport solution
that can extend the reach of SANs. ... 175 Km. WaveReady offers a simple
and reliable
transport solution for data center connectivity, ...
Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
... strategies for organ preservation during
transport from
donor to recipient will be a primary topic ... death. They
may suffer further injury during
transport to the recipient hospital. From
time-to-time, ... donor organs in a more
healthy state during
transport or even improve their function to ...
Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
... for a
safe and effective agent to improve oxygen
transport in clinical settings
where blood is often ... completed in the near future.
No similar oxygen
transport agents are currently on the market in
Europe or ... studied and defined mechanisms of
oxygen
transport by cell-free hemoglobin solutions, funded by ...
Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
... development and
commercialization of oxygen
transport agents, today announced that an
independent data ... Sangart.
Hemospan is a hemoglobin-based oxygen
transport agent designed to serve
as an oxygen therapeutic ... of medical products designed
for use as oxygen
transport agents.
Dr. Robert Winslow, a world-renowned ...
Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
... development and
commercialization of oxygen
transport agents, announced today that it has
started ... Sangart.
Hemospan is a hemoglobin-based oxygen
transport agent designed to serve
as an oxygen therapeutic ... of medical products designed
for use as oxygen
transport agents.
Dr. Robert Winslow, a world-renowned ...
Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
... HDL
oxidation and restore reverse cholesterol
transport function," said Noah
Berkowitz, M.D., Ph.D., ... for the defect in reverse cholesterol
transport observed in
many patients with diabetes mellitus ... promote less efficient reverse cholesterol
transport in
DM, which can be reversed by antioxidants such ...
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
... crosses the BBB through transcytosis, or the selective receptor-mediated
transport of peptides and large proteins across the endothelial membrane in the BBB. ... limited to the following statements: that NeuroTrans(TM) can effectively
transport diagnostic and therapeutic agents across the blood-brain barrier into the ...
Raptor Pharmaceuticals Provides Update on Targeting Platforms
... Raptor's NeuroTrans(TM) platform currently in
development to potentially
transport therapeutics from the blood to the
brain.
Dr. Christopher M. Starr, ... of potential therapeutics to its targeted
tissue; that NeuroTransTM may
transport therapeutics across the blood-brain
barrier; and that any of our clinical ...
Raptor Pharmaceuticals Provides Update of Product Programs
... cross the BBB. From these
experiments, the team selected a lead candidate
transport peptide called
RAP-2s. In this second year, the team will continue to ... drugs or to target the liver, the ability of RAP
peptides to enhance the
transport of molecules from blood to the brain, the
ability of Mesd or Mesd-based ...
Phosphagenics to Commence Phase 2 TPM/Insulin Clinical Trial
... patented transdermal carrier technology (TPM) utilises
natural dermal
transport mechanisms to rapidly
transport small and large
molecules across the skin without disrupting or damaging ...
Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
... patented transdermal carrier technology (TPM) utilises
natural dermal
transport mechanisms to rapidly
transport small and large
molecules across the skin without disrupting or damaging ...
Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
...
Asthma is a chronic lung disease characterized by inflammation of the air passages, resulting in the temporary narrowing of the airways that
transport air from the nose and mouth to the lungs.(2) Asthma symptoms can be triggered by allergens or irritants and can include difficulty breathing, ...
Sanofi-aventis Stands Behind the Safety of Lantus(R)
...
About Diabetes
Diabetes is a chronic, widespread condition in which the body does not produce or properly use insulin, the hormone needed to
transport glucose (sugar) from the blood into the cells of the body for energy. More than 230 million people worldwide are living with the disease and this ...
New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar
...
About Diabetes
Diabetes is a chronic, widespread condition in which the body does not produce or properly use insulin, the hormone needed to
transport glucose (sugar) from the blood into the cells of the body for energy. More than 230 million people worldwide are living with the disease and this ...
Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
... mucus over the surfaces
of the air passages in the lungs, removing debris and bacteria. In CF, an
inherited disease, a defective gene disrupts ion
transport across the
epithelial membrane within cells. In the lungs, this leads to a depletion of
the airway surface liquid that normally bathes the cilia, ...
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
... cell death.
"We considered an old drug for a new use," Dr. Ge said. "It looks like the increased drug activity or synergy is not due to the
transport or delivery of clofarabine, but to enhanced cell death. We were so pleased with the results."
AML afflicts mostly adults -- about 10,000 new ...
Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase
... protocol regionally for the past four years to exchange millions of transactions in our market. With the evolution to a national standard for secure
transport of health care information via the internet, CAQH's CORE, in conjunction with HITSP, have in effect offered a solution to make health information ...
Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research
... bios, is available on the Foundation's Web site -- www.michaeljfox.org .
Cerebrospinal Fluid (CSF) Biomarkers of Microtubule-mediated Axonal
transport for Monitoring of Disease Progression and Therapeutics Interventions in Parkinson's Disease
Patrizia Fanara, Ph.D., KineMed, Inc.
Selective ...
Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity
... vasculature arises from veins; and how lymphatic vessels can eventually lose their characteristics and acquire features typical of blood vessels and
transport blood -- a trick that might, for example, let the body quickly build up a supply of additional blood vessels when there is an emergency need for more ...
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
... About Diabetes
Diabetes is a chronic, widespread condition in which the body does not
produce or properly use insulin, the hormone needed to
transport glucose
(sugar) from the blood into the cells of the body for energy. In type 1
diabetes, the immune system destroys the insulin-producing beta cells ...
Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
... at the cellular level. Using
a novel mechanism of action, TSC enhances the diffusion of oxygen through
blood plasma, increasing the rate of oxygen
transport and thus treating the
symptoms of hypoxia at their source.
In 2007, the Company successfully completed a Phase I safety study of
TSC. This ...
Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
... a second-generation antisense drug currently in phase 3
development that reduces the production of apoB-100, a protein critical to
the synthesis and
transport of "bad" cholesterol.
In phase 2 studies, mipomersen, a weekly injectable therapeutic, was
observed to reduce cholesterol and other atherogenic ...
Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
... About Diabetes
Diabetes is a chronic, widespread condition in which the body does not
produce or properly use insulin -- the hormone needed to
transport glucose
(sugar) from the blood into the cells of the body for energy. More than 230
million people worldwide are living with the disease and this ...
Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADA's Recommended Target for Blood Sugar Control
... About Diabetes
Diabetes is a chronic, widespread condition in which the body does not
produce or properly use insulin -- the hormone needed to
transport glucose
(sugar) from the blood into the cells of the body for energy. More than 230
million people worldwide are living with the disease. This number ...
Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
... key roles in numerous biological processes such as neural signal
transduction, cardiac, skeletal, and smooth muscle contraction, and
epithelial
transport of nutrients and ions, among others, according to an
article in the June 1 issue of GEN
( http://www.genengnews.com/articles/chitem.aspx?aid=2484 ).
...
St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity
... mice whose T cells have variations
in the number and type of functional ITAMs. The technique involved using a
virus as a genetic cargo-carrier to
transport genes for different
combinations of normal and mutant non-functional ITAMs into the mouse
cells.
The researchers found that reducing the number ...
New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
... About Diabetes
Diabetes is a chronic, widespread condition in which the body does not
produce or properly use insulin, the hormone needed to
transport glucose
(sugar) from the blood into the cells of the body for energy. More than 230
million people worldwide are living with the disease and this ...
Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
... NeuroTrans(TM)
are currently undergoing evaluation at Stanford University in cell culture
and preclinical models for their ability to enhance the
transport of
molecules from blood to brain. In an effort to protect its novel approach,
Raptor Inc. currently has five patent applications in review in the ....
Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
... is a biopharmaceutical company focused on developing a
portfolio of internally discovered product candidates that utilize the
body's natural nutrient
transport mechanisms to improve the therapeutic
benefits of existing drugs. Its development and commercialization efforts
are currently focused on potential ...
Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
... of Hp-2-Hb and HDL in these mice. The study also
demonstrated that vitamin E supplementation prevented the impairment of
reverse cholesterol
transport in diabetic mice with the Hp2-2 genotype.
About Haptoglobin 2-2
The Hp protein is polymorphic in humans, occurring with two alleles, 1
and 2, ...
Hospital Launches Landmark Emergency Medicine Project
... edge therapies to
treat cancer, stroke and acute neurological injury and disease. Washington
Hospital Center is also home to MedSTAR Trauma and
transport and is the
region's adult burn facility.
...
Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
... folic acid (folate)-dependent enzyme
involved in the building of nucleic acid, or DNA, and other processes. PDX
was rationally designed for efficient
transport into tumor cells via the
reduced folate carrier, or RFC-1, and effective intracellular drug
retention. The Company believes these biochemical ...
Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
... service in the Washington, DC metropolitan
area, including the Metrorail and Metrobus; totaling more than 11,000 rail
cars, buses and special means
transport vehicles. Metro is also part of the
public- private partnership that operates the DC Circulator bus system.
Polly Hanson, Assistant General Manager ...
Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
... formerly ISIS 301012, is a second-generation antisense drug
that reduces the production of apoB-100, a protein critical to the
synthesis and
transport of "bad" cholesterol and a target that has proved
to be undruggable using traditional, small-molecule approaches. Cholesterol
can be carried in the ...
ABR-Affinity BioReagents to Exhibit in the U.S. Pavilion at Medica, November 14 - 17, 2007
... and encompassing Signal
Transduction, Vision Research, Neurobiology, Steroids & Hormones, Lipid and
Fat Metabolism Regulation, Phosphoproteins, Ion
transport and Muscle
Biology. We are proud to be able to contribute to life science research in
such a significant manner," Ms. Martin stated. ABR-Affinity ...
Cantel Medical Corp.'s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
... for infectious and
biological specimens. Cantel also provides technical maintenance for its
products and offers compliance training services for the
transport of
infectious and biological specimens. For further information, visit the
Cantel website at http://www.cantelmedical.com . Contact: R. Scott ...
Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
... in the Drug
Resistance Session A: Poster #192: "TPI 287, A Next Generation Taxane Derivative, Functionally Modulates MDR1 P-glycoprotein Drug
transport Pump and is Active in Resistant Tumor Cells" The poster outlines a number of different assays confirming Tapestry's
observation that its lead ...
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
... published animal studies demonstrate that lower doses
of GLP-2 can enhance nutrient absorption through enhancement of mechanisms
promoting nutrient
transport across the gut epithelium and via improved
intestinal cell survival, while higher doses of GLP-2 can result in mucosal
regeneration. These ...
Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
... SLx-4090 using
its proprietary small molecule Pharmacomer(TM) technology to act
specifically in the gastrointestinal (GI) tract to prevent the
transport of
fats through the intestinal wall. This unique feature of intestinal
selectivity allows potent activity against fat uptake while avoiding
toxicity ...
Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
... folic acid (folate)-dependent enzyme
involved in the building of nucleic acid, or DNA, and other processes. PDX
was rationally designed for efficient
transport into tumor cells via the
reduced folate carrier, or RFC-1, and effective intracellular drug
retention. The Company believes these biochemical ...